About
Acadia Pharmaceuticals develops novel therapies for neurological disorders and rare diseases, focusing on underserved patient communities such as those affected by Parkinson's Disease Psychosis, Rett Syndrome, and Alzheimer's Disease Psychosis.
Explore Acadia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.